FDA Authorizes Emergency Use of H1N1 Test for US Troops Overseas
The FDA announces it has issued an Emergency Use Authorization (EUA) that allows a 2009 H1N1 influenza virus test to be used to detect the virus in troops serving overseas.
Read MoreMonth: August 2009
MicroRNA in Human Saliva May Help Diagnose Oral Cancer
Researchers continue to add to the diagnostic alphabet of saliva by identifying the presence of at least 50 microRNAs that could aid in the detection of oral cancer, according to a new report.
Read MoreTop Ten Medical Device Technologies Market Worth $454 Billion by 2014
According to a new healthcare market research report, the entire market for top ten medical device technologies is estimated to be approximately $454.3 billion, of which medical diagnostic devices technologies alone constitute about $177.8 billion.
Read MoreCardioDx Completes Validation Study of Genomic Test for Coronary Artery Disease
CardioDx, a cardiovascular genomic diagnostics company, announces that the company has successfully completed its multicenter validation study for Corus CAD, the first and only gene expression test to quantify the likelihood of obstructive coronary artery disease (CAD) in patients with stable chest pain.
Read MoreProdesse Receives Special 510(k) for ProFlu+ Assay for 2009 H1N1 Influenza
Prodesse Inc announces that reactivity testing completed by the company confirms that its ProFlu+ test correctly identifies as Influenza A positive specimens containing Novel 2009 H1N1 influenza virus
Read More